Literature DB >> 30417696

Periodontal sources of citrullinated antigens and TLR agonists related to RA.

Ljubomir Vitkov1,2, Matthias Hannig2, Bernd Minnich1, Martin Herrmann3.   

Abstract

Anti-citrullinated protein autoantibodies (ACPA) precede the onset of clinical and subclinical rheumatoid arthritis (RA). ACPA are frequently generated in further chronic inflammatory diseases, e.g. chronic obstructive pulmonary disease, lupus, periodontitis (PD), characterized by citrullination and mucosal as well as systemic autoimmunity against citrullinated proteins. PD is of particular interest, as it exhibits two sources of citrullination, namely peptidylarginine deiminase 4 (PAD4) of periodontal neutrophils and neutrophil extracellular traps (NETs) as well as the PAD of Porphyromonas gingivalis (PPAD). Whereas the PAD4-citrullinated host peptides and/or proteins occur physiologically, PPAD-citrullinated ones appear under pathological conditions as neo-antigens. Frequently, the oral pathogens P. gingivalis and A. actinomycetemcomitans directly and indirectly participate in synovitis in RA, providing topical citrullination: P. gingivalis via PPAD and A. actinomycetemcomitans via leukotoxin A-mediated ROS-independent NET formation. In addition, transient bacteraemia due to tooth brushing indicates the possibility that citrullinated peptides and/or proteins from periodontium regularly enter the blood circulation. In this way, the mucosal firewall is evaded and the systemic immune response against citrullinated peptides and/or proteins is facilitated. However, the role of swallowed PD-derived sludge for the induction of oral tolerance remains to be established. We hypothesize (I) PD-driven endotoxemia may increase the host responsiveness to autoantigens via TLR4 activation and (II) this participates in development and propagation of RA (III) circulating PD-derived bacterial DNA is taken up by phagocytes, activates TLR9, and thus increases the responsiveness to autoantigens.

Entities:  

Keywords:  GCF; LPS; PAD; PPAD; Porphyromonas gingivalis; cross-reactivity; mucosal firewall

Mesh:

Substances:

Year:  2018        PMID: 30417696     DOI: 10.1080/08916934.2018.1527907

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  7 in total

Review 1.  Neutrophil Extracellular Traps in Periodontitis.

Authors:  Antonio Magán-Fernández; Sarmad Muayad Rasheed Al-Bakri; Francisco O'Valle; Cristina Benavides-Reyes; Francisco Abadía-Molina; Francisco Mesa
Journal:  Cells       Date:  2020-06-19       Impact factor: 6.600

Review 2.  NETs Are Double-Edged Swords with the Potential to Aggravate or Resolve Periodontal Inflammation.

Authors:  Ljubomir Vitkov; Bernd Minnich; Jasmin Knopf; Christine Schauer; Matthias Hannig; Martin Herrmann
Journal:  Cells       Date:  2020-12-05       Impact factor: 6.600

Review 3.  Oral Dysbiosis and Autoimmunity: From Local Periodontal Responses to an Imbalanced Systemic Immunity. A Review.

Authors:  Lina J Suárez; Hernan Garzón; Silie Arboleda; Adriana Rodríguez
Journal:  Front Immunol       Date:  2020-12-08       Impact factor: 7.561

4.  Potential Immunologic and Integrative Methods to Enhance Vaccine Safety.

Authors:  Alan M Dattner
Journal:  Vaccines (Basel)       Date:  2022-07-11

Review 5.  Potential roles of gut microbiota and microbial metabolites in chronic inflammatory pain and the mechanisms of therapy drugs.

Authors:  Jia-Shang Li; Shu-Lan Su; Zhuo Xu; Li-Hui Zhao; Ruo-Ying Fan; Jian-Ming Guo; Da-Wei Qian; Jin-Ao Duan
Journal:  Ther Adv Chronic Dis       Date:  2022-07-28       Impact factor: 4.970

Review 6.  Linkage of Periodontitis and Rheumatoid Arthritis: Current Evidence and Potential Biological Interactions.

Authors:  Rafael Scaf de Molon; Carlos Rossa; Rogier M Thurlings; Joni Augusto Cirelli; Marije I Koenders
Journal:  Int J Mol Sci       Date:  2019-09-13       Impact factor: 5.923

Review 7.  Periodontal Pathogens' strategies disarm neutrophils to promote dysregulated inflammation.

Authors:  Irina Miralda; Silvia M Uriarte
Journal:  Mol Oral Microbiol       Date:  2020-12-31       Impact factor: 3.563

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.